Friday 6 November 2026 Export XRAY’s income statement to Excel — free account

DENTSPLY SIRONA Inc.

XRAY Healthcare Medical Instruments & Supplies

DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024.

Revenue: −7.52%
EPS: +99.5%
Free cash flow: −18.0%
Total debt: −1.59%

Quarter to September 2026, against a year earlier

9.59 0.50 −4.96%

Follow XRAY

Alert me

Market cap: $2.0B
P/E: 0.0×
Fwd P/E: 24.5×
Dividend yield: 1.59%
F-score: 6/9
Altman Z: 0.50
Beneish M: −3.03
Dividend safety: 22/100

Overview

DENTSPLY SIRONA Inc. (XRAY) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, DENTSPLY SIRONA Inc. (XRAY) trades at a price to free cash flow of 21.1×. Over the past ten years it has ranged from 9.2× (April 2025) to 45.6× (July 2023); the current reading is higher than 41% of that period. That is below the Medical Instruments & Supplies industry median of 23.5× and in line with the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/XRAY/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="DENTSPLY SIRONA Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/XRAY/metrics/price-to-free-cash-flow">DENTSPLY SIRONA Inc. (XRAY) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	23.0×	64.75%
FY2024	14.0×	(58.75%)
FY2023	33.9×	74.54%
FY2022	19.4×	(18.77%)
FY2021	23.9×	15.95%
FY2020	20.6×	(16.60%)
FY2019	24.7×	(4.98%)
FY2018	26.0×	(22.63%)
FY2017	33.6×	14.97%
FY2016	29.2×	44.35%

Period	Price to free cash flow	Change
Sep 2026	18.6×	24.51%
Jun 2026	14.9×	(36.30%)
Mar 2026	23.4×	1.74%
Dec 2025	23.0×	(31.80%)
43 more quarters	Free account

Against its own ten years

Low 9.2× High 45.6×

Ten-year median 22.7×

Current reading's percentile 41

Company	Price to free cash flow
STVN Stevanato Group S.p.A. compare	n/m
PLSE Pulse Biosciences, Inc compare	n/m
KMTS Kestra Medical Technologies, Ltd. compare	n/m
XRAY DENTSPLY SIRONA Inc.	21.1×
LMAT LeMaitre Vascular, Inc. compare	28.3×
STAA STAAR Surgical Company compare	75.3×
ATRC AtriCure, Inc. compare	129×
WRBY Warby Parker Inc. compare	153×
AZTA Azenta, Inc. compare	172×
Medical Instruments & Supplies industry median	23.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

DENTSPLY SIRONA Inc. (XRAY) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on XRAY

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on XRAY

Stockrow Weekly